---
$id: https://graph.org.ai/products/commodity/51442415
$type: Product
source: UNSPSC
code: "51442415"
title: "Iodoxamate or iodoxamate meglumine or iodoxamic acid"
class: "51442400"
classTitle: "Iodine-based radiopharmaceuticals, imaging agents, media, and tracers"
family: "51440000"
familyTitle: "Radiopharmaceuticals and contrast media"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Iodoxamate or iodoxamate meglumine or iodoxamic acid

**UNSPSC Code**: 51442415
**Class**: [Iodine-based radiopharmaceuticals, imaging agents, media, and tracers](Iodine-based radiopharmaceuticals, imaging agents, media, and tracers.mdx)
**Family**: [Radiopharmaceuticals and contrast media](../Radiopharmaceuticals and contrast media.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an iodinated contrast dye with the molecular formula C26H26I6N2O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NS1Y283HW4, chemically known as 4,7,10,13-tetraoxahexadecane-1,16-dioyl-bis(3-carboxytriiodoanilide) but more generally known as iodoxamic acid, which bears U.S. National Institutes of Health Compound Identifier 35740. The European Medicines Agency schedules Iodoxamic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08218MIG. The term IODOXAMIC ACID is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 26, No. 10 1972, List 12). The World Health Organization schedules iodoxamic acid in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: Ic1c(NC(=O)CCOCCOCCOCCOCCC(=O)Nc2c(I)c(c(I)cc2I)C(=O)O)c(I)cc(I)c1C(=O)O. Most nations schedule Iodoxamate or iodoxamate meglumine or iodoxamic acid under HS 29242995.

